Orexo sues Sun Pharma over opioid dependence generic

16-09-2020

Sarah Morgan

Orexo sues Sun Pharma over opioid dependence generic

Pavel Kapysh / Shutterstock.com

Swedish pharmaceutical company Orexo has taken India-based Sun Pharmaceutical to court in the US, over its plans to launch a generic version of Orexo’s opioid dependence treatment.


Orexo, Sun Pharma, opioid treatment, generics, ANDA, FDA, Zubsolv, patent infringement

LSIPR